Page last updated: 2024-08-17

medroxyprogesterone acetate and Gonorrhea

medroxyprogesterone acetate has been researched along with Gonorrhea in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (66.67)	29.6817
2010's	1 (16.67)	24.3611
2020's	1 (16.67)	2.80

Authors

Authors	Studies
Ahmed, K; Baeten, JM; Batting, J; Beksinska, M; Deese, J; Donnell, D; Edward, VA; Lind, M; Louw, CE; Mastro, TD; Morrison, C; Mugo, NR; Nanda, K; Onono, M; Palanee-Phillips, T; Philip, N; Rees, H; Smit, JA	1
Gursahaney, PR; Hillier, SL; Meyn, LA; Sweet, RL; Wiesenfeld, HC	1
Castaño, PM; Stuart, GS	1
MacLean, R	1
Bahamondes, L; Caraway, J; Condon, S; El-Shafei, M; Feldblum, PJ; Morales, E; Quan Ha, D; Wevill, S	1
Baeten, JM; Bwayo, JJ; Chohan, B; Kreiss, JK; Lavreys, L; Mandaliya, K; Martin, HL; Ndinya-Achola, JO; Nyange, PM; Richardson, BA	1

Reviews

1 review(s) available for medroxyprogesterone acetate and Gonorrhea

Article	Year
Sexually transmitted infections and contraceptives: selective issues. Obstetrics and gynecology clinics of North America, 2003, Volume: 30, Issue:4 Topics: Chlamydia Infections; Condoms; Contraception; Contraceptive Devices, Female; Contraceptives, Oral; Female; Gonorrhea; HIV Infections; Humans; Intrauterine Devices; Male; Medroxyprogesterone Acetate; Papillomaviridae; Pelvic Inflammatory Disease; Sexually Transmitted Diseases	2003

Article

Year

Sexually transmitted infections and contraceptives: selective issues.

Obstetrics and gynecology clinics of North America, 2003, Volume: 30, Issue:4

Topics: Chlamydia Infections; Condoms; Contraception; Contraceptive Devices, Female; Contraceptives, Oral; Female; Gonorrhea; HIV Infections; Humans; Intrauterine Devices; Male; Medroxyprogesterone Acetate; Papillomaviridae; Pelvic Inflammatory Disease; Sexually Transmitted Diseases

2003

Trials

2 trial(s) available for medroxyprogesterone acetate and Gonorrhea

Article	Year
Sexually transmitted infections among women randomised to depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant. Sexually transmitted infections, 2021, Volume: 97, Issue:4 Topics: Adolescent; Adult; Africa; Chlamydia Infections; Contraception; Contraceptive Agents, Female; Delayed-Action Preparations; Disease Susceptibility; Drug Implants; Female; Gonorrhea; Humans; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone Acetate; Prevalence; Young Adult	2021
Randomized assignment to copper IUD or depot-medroxyprogesterone acetate: feasibility of enrollment, continuation and disease ascertainment. Contraception, 2005, Volume: 72, Issue:3 Topics: Adolescent; Adult; Chlamydia Infections; Contraceptive Agents, Female; Feasibility Studies; Female; Gonorrhea; Humans; Intrauterine Devices, Copper; Medroxyprogesterone Acetate; Pelvic Inflammatory Disease; Pilot Projects	2005

Article

Year

Sexually transmitted infections among women randomised to depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant.

Sexually transmitted infections, 2021, Volume: 97, Issue:4

Topics: Adolescent; Adult; Africa; Chlamydia Infections; Contraception; Contraceptive Agents, Female; Delayed-Action Preparations; Disease Susceptibility; Drug Implants; Female; Gonorrhea; Humans; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone Acetate; Prevalence; Young Adult

2021

Randomized assignment to copper IUD or depot-medroxyprogesterone acetate: feasibility of enrollment, continuation and disease ascertainment.

Contraception, 2005, Volume: 72, Issue:3

Topics: Adolescent; Adult; Chlamydia Infections; Contraceptive Agents, Female; Feasibility Studies; Female; Gonorrhea; Humans; Intrauterine Devices, Copper; Medroxyprogesterone Acetate; Pelvic Inflammatory Disease; Pilot Projects

2005

Other Studies

3 other study(ies) available for medroxyprogesterone acetate and Gonorrhea

Article	Year
Combined hormonal contraception may be protective against Neisseria gonorrhoeae infection. Sexually transmitted diseases, 2010, Volume: 37, Issue:6 Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Female; Gonorrhea; Humans; Interviews as Topic; Longitudinal Studies; Male; Medroxyprogesterone Acetate; Neisseria gonorrhoeae; Sexual Behavior; Treatment Outcome; Urethritis; Uterine Cervicitis; Young Adult	2010
Injectable use may increase women's odds of getting chlamydia or gonorrhea. International family planning perspectives, 2005, Volume: 31, Issue:1 Topics: Administration, Oral; Adolescent; Adult; Baltimore; Cervix Uteri; Chlamydia Infections; Contraception; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Female; Gonorrhea; Humans; Medroxyprogesterone Acetate; Risk Factors; Sexually Transmitted Diseases; Uterine Cervical Diseases	2005
Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study. American journal of obstetrics and gynecology, 2001, Volume: 185, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Candidiasis, Vulvovaginal; Chlamydia Infections; Cohort Studies; Condoms; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Female; Gonorrhea; Humans; Kenya; Medroxyprogesterone Acetate; Middle Aged; Pelvic Inflammatory Disease; Prospective Studies; Risk Factors; Sex Work; Sexual Behavior; Sexually Transmitted Diseases; Trichomonas Vaginitis; Vaginosis, Bacterial	2001